Obstructive sleep apnea syndrome and autonomic dysfunction in Duchenne muscular dystrophy.

Apnea-hypopnea index Cardiac autonomic function Duchenne muscular dystrophy Heart rate variability LF/HF ratio Obstructive sleep apnea syndrome

Journal

Sleep & breathing = Schlaf & Atmung
ISSN: 1522-1709
Titre abrégé: Sleep Breath
Pays: Germany
ID NLM: 9804161

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 05 05 2020
accepted: 24 06 2020
revised: 18 06 2020
pubmed: 3 8 2020
medline: 18 12 2021
entrez: 3 8 2020
Statut: ppublish

Résumé

Cardiac and respiratory involvement constitutes serious complications of Duchenne muscular dystrophy (DMD). We hypothesized that obstructive sleep apnea syndrome (OSAS) may play a role in cardiac autonomic dysfunction in DMD. We sought to assess the presence of cardiac autonomic function in patients with DMD by analyzing heart rate variability (HRV) during polysomnography (PSG). In a prospective study, all participants had whole-night PSG recorded and scored according to American Academy of Sleep Medicine guidelines. HRV analysis was performed on electrocardiography recordings from PSG recordings. Twelve consecutive males with DMD (mean age 9.0 ± 3.1 years, mean BMI 20.6 ± 4.8 kg/m2) and eight age-matched healthy males were enrolled. On clinical evaluation, 58% of patients with DMD had at least one symptom related to OSAS, such as snoring, witnessed apnea, or restless sleep. None of the controls had OSAS-related complaints. By PSG none of the controls had OSAS, while 42% of patients with DMD had OSAS (p = 0.004). Average R-R duration and mean percentage of successive R-R intervals > 50 ms values were significantly lower in patients with DMD than those in controls (p < 0.006). In patients with DMD and OSAS, LF/HF (low/high-frequency) ratio was significantly increased in NREM sleep compared with those in controls (p = 0.005). Higher apnea-hypopnea index and lower oxygen saturation showed significant correlations with higher LF power and LF/HF ratio (p < 0.001). Cardiac autonomic dysfunction is present in DMD, being more pronounced in the presence of OSAS.

Identifiants

pubmed: 32740854
doi: 10.1007/s11325-020-02139-5
pii: 10.1007/s11325-020-02139-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

941-946

Références

Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277
doi: 10.1016/0167-5273(90)90082-G
Fayssoil A, Abasse S, Silverston K (2017) Cardiac involvement classification and therapeutic management in patients with Duchenne muscular dystrophy. J Neuromusc Dis 4:17–23
doi: 10.3233/JND-160194
Spurney CF (2011) Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44:8–19
doi: 10.1002/mus.22097
Ashwath ML, Jacobs IB, Crowe CA, Ashwath RC, Super DM, Bahler RC (2014) Left ventricular dysfunction in muscular dystrophy and genotype. Am J Cardiol 114:284–289
doi: 10.1016/j.amjcard.2014.04.038
Thayer JF, Yamamoto SS, Brosschot JF (2010) The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 141:122–131
doi: 10.1016/j.ijcard.2009.09.543
Inoue M, Mori K, Hayabuchi Y, Tatara K, Kagami S (2009) Autonomic function in patients with duchenne muscular dystrophy. Pediatr Int 51:33–40
doi: 10.1111/j.1442-200X.2008.02656.x
Thomas TO, Morgan TM, Burnette WB, Markham LW (2012) Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy. Pediatr Cardiol 33:1175–1179
doi: 10.1007/s00246-012-0281-0
Thomas TO, Jefferies JL, Lorts A, Anderson JB, Gao Z, Benson DW et al (2015) Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients? Pediatr Cardiol 36:561–568
doi: 10.1007/s00246-014-1050-z
Sawnani H (2019) Sleep disordered breathing in Duchenne muscular dystrophy. Paediatr Respir Rev 30:2–8
pubmed: 30153979
Flevari A, Vagiakis E, Zakynthinos S (2015) Heart rate variability is augmented in patients with positional obstructive sleep apnea, but only supine LF/HF index correlates with its severity. Sleep Breath 19:359–367
doi: 10.1007/s11325-014-1029-2
Gula L, Krahn A, Skanes A, Ferguson KA, George C, Yee R et al (2003) Heart rate variability in obstructive sleep apnea: a prospective study and frequency domain analysis. Ann Noninvasive Electrocardiol 8:144–149
doi: 10.1046/j.1542-474X.2003.08209.x
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:485–491
doi: 10.7326/0003-4819-131-7-199910050-00002
American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
Berry RB, Albertario CL, Harding SM, for the American Academy of Sleep Medicine (2018) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. American Academy of Sleep Medicine, Darien
Lanza GA, Dello Russo A, Giglio V, De Luca L, Messano L, Santini C et al (2001) Impairment of cardiac autonomic function in patients with duchenne muscular dystrophy: relationship to myocardial and respiratory function. Am Heart J 141:808–812
doi: 10.1067/mhj.2001.114804
Mosqueira M, Zeiger U, Forderer M, Brinkmeier H, Fink RH (2013) Cardiac and respiratory dysfunction in duchenne muscular dystrophy and the role of second messengers. Med Res Rev 33:1174–1213
doi: 10.1002/med.21279

Auteurs

Gulcin Benbir Senel (GB)

Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey. drgulcinbenbir@yahoo.com.

N Burcu Arkali (NB)

Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Huseyin Kilic (H)

Cerrahpasa Faculty of Medicine, Department of Pediatrics, Division of Child Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Gunduz Incesu (G)

Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Sema Saltik (S)

Cerrahpasa Faculty of Medicine, Department of Pediatrics, Division of Child Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Cengiz Yalcinkaya (C)

Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Derya Karadeniz (D)

Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH